Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today. Net sales decreased 11.4% year-over-year to $10 billion. Organic sales growth, excluding
Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results
Categories
Health Care
Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion. GAAP net
Novartis AG (NVS) Q2 2023 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah -- Global Head, Investor Relations Vasant (Vas) Narasimhan -- Chief
A look at the factors that influenced UnitedHealth’s Q2 earnings
Health insurance company UnitedHealth Group (NYSE: UNH) reported strong second-quarter results last week, triggering a stock rally. The company also strengthened its
UnitedHealth Group Incorporated (UNH) Q2 2023 Earnings Call Transcript
UnitedHealth Group Incorporated (NYSE: UNH) Q2 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk McMahon -- Chief Operating
Organigram Holdings Inc (OGI) Q3 2023 Earnings Call Transcript
Organigram Holdings Inc (NASDAQ: OGI) Q3 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations Beena Goldenberg -- Chief
Earnings Preview: Here’s what to expect from Johnson & Johnson’s Q2
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move is part
Infographic: Highlights of UnitedHealth Group’s (UNH) Q2 2023 earnings
Diversified healthcare company UnitedHealth Group (NYSE: UNH) reported higher earnings and revenues for the second quarter of 2023. The company also raised
Theratechnologies Inc (THTX) Q2 2023 Earnings Call Transcript
Theratechnologies Inc (NASDAQ: THTX) Q2 2023 earnings call dated Jul. 12, 2023 Corporate Participants: John Mullaly -- Managing Director, LifeSci Advisors, LLC Paul Levesque -- President
Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer -- Chief Executive Officer Steve Trowbridge -- Chief Financial Officer
Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%
Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of 2023, aided
Ocean Biomedical focuses its malaria program to address chronic malaria crisis in sub-Saharan Africa
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it is focusing its multi-pronged malaria program to address the chronic malaria
UnitedHealth (UNH) looks poised to report strong Q2 results
Over the years, UnitedHealth Group Incorporated (NYSE: UNH) has grown into a diversified healthcare conglomerate as it keeps investing in the business
Apogee Therapeutics set to go public. Here’s what you need to know
The US IPO market has remained mostly sluggish so far this year, continuing the weakness experienced in 2022. Meanwhile, there is speculation
Rite Aid Corp. (RAD) Q1 2024 adj. loss narrows; revenue down 6%
Drugstore chain Rite Aid Corporation (NYSE: RAD) announced first-quarter results, reporting lower revenues and a narrower adjusted loss. First-quarter loss, excluding special
Walgreens Boots Alliance, Inc. (WBA) Q3 2023 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q3 2023 earnings call dated Jun. 27, 2023 Corporate Participants: Tiffany Kanaga -- Vice President of Global Investor
Walgreens Boots Alliance (WBA) Q3 adj. profit rises on higher revenues
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Tuesday said its third-quarter sales rose 9%. As a result, the healthcare service company’s adjusted
Superlatus names Dr. Eugenio Bortone COO; interim CEO Tim Alford to become CCO
Superlatus, Inc., a holding company of food products and distribution capabilities, on Tuesday, announced new appointments to its management team. The company
Ocean Biomedical (OCEA) joins the Russell 2000 Index
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market Russell 3000
Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a new, broad
Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform
Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be acquired by